Chris Hulme
co-founder, CSO
About
Co-founder/CSO Iluminos Therapeutics. Developing ultra-selective Dyrk1a inhibitors for Alzheimer’s, down syndrome and T1D. Lead small molecule asset DYR533 has completed CMC GMP manufacturing. Lead PROTAC asset has completed evaluation in non-diabetic and diabetic mouse models.
United States
Greater Tucson Area
Biotechnology
Drug Discovery, Organic Chemistry, Teaching, Neuroscience, Parallel Synthesis, Small Molecules, Cancer Therapeutics, Protein Kinases, Drug Design, Medicinal Chemistry
Experience
co-founder, CSO
Branch Therapeutics Inc.
Tucson, Arizona, United States
Co-Director Arizona Center for Drug Discovery
University of Arizona
Professor Medicinal & Organic Chemistry
University of Arizona
Tucson, Arizona Area
Director and Founder - South West Center for Drug Discovery and Development (SC2D3)
University of Arizona
Oro Valley, Arizona
Co-Founder
Iluminos Therapeutics
Tucson, Arizona Area
Head High-throughput Medicinal Chemistry/Platform Library Sciences
Eli Lilly and Company
Indianapolis, Indiana Area
Head of High-throughput Medicinal Chemistry
Amgen
Thousand Oaks, California
Research Advisor New Lead Generation
Sanofi
Collegeville
Education
University of Oxford
Organic Chemistry
The University of Texas at Austin
University of Oxford
Chemistry
Chris Hulme's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.